| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $2.73B | -1.9% |
| R&D Expense | $186.2M | -14.9% |
| SG&A Expense | $746.3M | -2.7% |
| Operating Income | -$919.2M | +53.1% |
| Pre-tax Income | -$1.11B | +48.0% |
| Income Tax | $24.1M | +130.3% |
| Net Income | -$1.13B | +44.8% |
| EPS (Basic) | -$16.69 | +45.4% |
| EPS (Diluted) | -$16.69 |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $169.8M | +72.7% |
| Accounts Receivable | $417.0M | +47.7% |
| Inventory | $577.6M | +8.2% |
| Current Assets | $1.45B | +18.7% |
| Total Assets | $5.77B | -10.2% |
| Current Liabilities | $966.1M | -3.3% |
| Long-term Debt | $2.70B | +8.4% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $105.2M | +26.7% |
| Capital Expenditures | $188.2M | -3.5% |
| Investing Cash Flow | -$192.7M | -28.6% |
| Financing Cash Flow | $155.8M | +219.3% |
| Free Cash Flow | -$83.0M | +26.0% |
| +45.4% |
| Total Liabilities |
| $3.85B |
| +11.9% |
| Stockholders' Equity | $1.92B | -35.7% |